Company Filing History:
Years Active: 2019
Title: Adam Henke - Innovator in Mu-Opioid Receptor Agonists
Introduction
Adam Henke is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of mu-opioid receptor agonists. His work is essential in advancing therapeutic options for pain management.
Latest Patents
Adam Henke holds a patent for a compound classified as a mu-opioid receptor agonist. This invention provides a compound having a specific structure or a pharmaceutically acceptable salt or ester thereof. His innovative approach aims to enhance the efficacy and safety of pain relief medications.
Career Highlights
Adam Henke is affiliated with Columbia University, where he engages in research and development in the pharmaceutical sciences. His academic background and research focus have positioned him as a key figure in his field.
Collaborations
Some of his notable coworkers include Andrew Carry Kruegel and Madalee M Gassaway. Their collaborative efforts contribute to the advancement of research in pharmacology and related disciplines.
Conclusion
Adam Henke's work in mu-opioid receptor agonists exemplifies the impact of innovative research in medicine. His contributions are vital for the future of pain management therapies.